VHCP Management as of Sept. 30, 2011
Portfolio Holdings for VHCP Management
VHCP Management holds 16 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 17.4 | $26M | 2.4M | 10.80 | |
| Neurocrine Biosciences (NBIX) | 11.8 | $18M | 2.9M | 5.98 | |
| Chelsea Therapeutics International | 9.6 | $14M | 3.9M | 3.64 | |
| NPS Pharmaceuticals | 8.5 | $13M | 1.9M | 6.51 | |
| Anacor Pharmaceuticals In | 7.7 | $11M | 2.0M | 5.70 | |
| Medivation | 7.4 | $11M | 650k | 16.98 | |
| Ardea Biosciences | 5.7 | $8.5M | 545k | 15.62 | |
| DepoMed | 5.3 | $7.9M | 1.5M | 5.40 | |
| DURECT Corporation | 4.8 | $7.2M | 4.4M | 1.61 | |
| GTx | 4.8 | $7.1M | 2.1M | 3.35 | |
| Affymax (AFFY) | 4.1 | $6.0M | 1.4M | 4.48 | |
| Antares Pharma | 3.3 | $4.9M | 2.1M | 2.32 | |
| Zogenix | 3.1 | $4.6M | 2.5M | 1.83 | |
| ACADIA Pharmaceuticals (ACAD) | 2.4 | $3.6M | 3.4M | 1.08 | |
| Anthera Pharmaceuticals | 2.2 | $3.2M | 675k | 4.77 | |
| InterMune | 1.8 | $2.7M | 135k | 20.20 |
